Company
Samsung Biologics
WatchContract development and manufacturing organisation at Songdo, Incheon, with the largest single-site biologics capacity in the world. Clients include most of the European large-cap pharma groups.
Standing view
The desk's standing view: Samsung Biologics is where European pharma's Korean exposure is concentrated, and it is a capacity story before it is a price story. Plant five brings Songdo past 780,000 litres, and the group is separating its biosimilar business from the CDMO to remove client conflict.
Negotiations with Songdo run on a timeline logic that European procurement teams tend to under-weight. The desk covers that in the culture and negotiation vertical.
On the desk
Nothing published on Samsung Biologics yet. Sign in and watch it to be told when there is.